Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 11, 2016, Pages 4219-4228

  Shojaee Moradie, F ^a   Cuthbertson, D J ^b   Barrett, M ^a   Jackson, N C ^a   Herring, R ^d   Thomas, E L ^c   Bell, J ^c   Kemp, G J ^b   Wright, J ^d   Umpleby, A M ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ADULT; AEROBIC EXERCISE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE INTENSITY; FEMALE; HUMAN; HUMAN TISSUE; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; METABOLIC RATE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; THERAPY EFFECT; TREATMENT DURATION; BLOOD; KINETICS; LIVER; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROCEDURES;

ADIPOSITY; APOLIPOPROTEINS B; EXERCISE THERAPY; HUMANS; KINETICS; LIPOPROTEINS, VLDL; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OUTCOME ASSESSMENT (HEALTH CARE); SEDENTARY LIFESTYLE; TRIGLYCERIDES;

EID: 84994852229     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2353     Document Type: Article

References (40)

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of non-alcoholic fatty liver disease-metaanalytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64(1):73-84.
2. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450-455.
3. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343-1351.
4. Dallinga-Thie GM, Franssen R, Mooij HL, et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis. 2010;211(1):1-8.
5. Malmstrom R, Packard CJ, Caslake M, et al. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes. 1998;47(5):779-787.
6. Sidiropoulos KG, Pontrelli L, Adeli K. Insulin-mediated suppression of apolipoprotein B mRNA translation requires the 5 UTR and is characterized by decreased binding of an insulin-sensitive 110-kDa 5 UTR RNA-binding protein. Biochemistry. 2005;44(37):12572-12581.
7. Au WS, Kung HF, Lin MC. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes. 2003;52(5):1073-1080.
8. Sparks JD, O'Dell C, Chamberlain JM, Sparks CE. Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases. Biochem Biophys Res Commun. 2013;435(4):616-620.
9. Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49(4):755-765.
10. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54(3):603-608.
11. Lazo M, Solga SF, Horska A, et al. Effects of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156-2163.
12. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278-1283.
13. Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50(4):1105-1112.
14. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55(6):1738-1745.
15. Shojaee-Moradie F, Baynes KC, Pentecost C, et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia. 2007;50(2):404-413.
16. Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2016;130(2):93-104.
17. Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 2005;54(1): 122-127.
18. Thomas EL, Fitzpatrick JA, Malik SJ, Taylor-Robinson SD, Bell JD. Whole body fat: content and distribution. Prog Nucl Magn Reson Spectrosc. 2013;73:56-80.
19. Watts GF, Mandalia S, Brunt JN, Slavin BM, Coltart DJ, Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism. 1993; 42(11):1461-1467.
20. Alam S, Stolinski M, Pentecost C, et al. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(2): 688-694.
21. Sarac I, Backhouse K, Shojaee-Moradie F, et al. Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men. J Clin Endocrinol Metab. 2012;97(7):2475-2481.
22. D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation. 2008;117(6):743-753.
23. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191-2202.
24. Al-Shayji IA, Caslake MJ, Gill JM. Effects of moderate exercise on VLDL1 and intralipid kinetics in overweight/obese middle-aged men. Am J Physiol Endocrinol Metab. 2012;302(3):E349-E355.
25. Bellou E, Magkos F, Kouka T, et al. Effect of high-intensity interval exercise on basal triglyceride metabolism in non-obese men. Appl Physiol Nutr Metab. 2013;38(8):823-829.
26. Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia. 2008;51(1):130-138.
27. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in nondiabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48(4):634-642.
28. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 1991; 11(5):1192-1203.
29. Bergeron J, Couillard C, Després JP, et al. Race differences in the response of postheparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE Family Study. Atherosclerosis. 2001;159(2):399-406.
30. Chan DC, Gan SK, Wong AT, Barrett PH, Watts GF. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Diabetes Obes Metab. 2014;16(10):994-1000.
31. Mittendorfer B, Patterson BW, Klein S. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab. 2003;284(3):E549-E556.
32. Kallwitz ER, Guzman G, TenCate V, et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol. 2009;104(1): 64-69.
33. Zhang YL, Hernandez-Ono A, Ko C, Yasunaga K, Huang LS, Ginsberg HN. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J Biol Chem. 2004;279(18):19362-19374.
34. Gill JM, Al-Mamari A, Ferrell WR, et al. Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis. 2006; 185(1):87-96.
35. Bjorkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res. 1996;37(1):76-86.
36. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010; 363(14):1341-1350.
37. Vlachopoulos C, Manesis E, Baou K, et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study. Am J Hypertens. 2010;23(11):1183-1189.
38. DattiloAM,Kris-EthertonPM.Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992; 56(2):320-328.
39. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia. 2012; 55(4):885-904.
40. Hens W, Taeyman J, Cornelis J, Gielen J, Van Gaal L, Vissers D. The effect of lifestyle interventions on excess ectopic fat deposition measured by noninvasive techniques in overweight and obese adults: a systematic review and meta-analysis. J Phys Act Health. 2016;13(6): 671-694.